CC logo

Chemours Company (The) (CC)

$12.48

Quotes are delayed by 15 minutes.

1D

1W

1M

3M

6M

YTD

1Y

2Y

5Y

ALL

Key data on CC

Market cap

$1.88B

EPS

-1.11

P/E ratio

--

Price to sales

0.35

Dividend yield

2.804%

Beta

1.473974

Price on CC

Previous close

$13.29

Today's open

$12.94

Day's range

$12.41 - $13.06

52 week range

$10.44 - $28.67

Profile about CC

CEO

Denise M. Dignam

Employees

5700

Headquarters

Wilmington, DE

Exchange

New York Stock Exchange

Shares outstanding

150534489

Issue type

Common Stock

CC industries and sectors

Materials

Chemicals

News on CC

CC Investor Alert: The Chemours Company Securities Class Action Notice - Contact SueWallSt

Important Information Regarding Section 20(a) Individual Liability Claims: The lawsuit names Chemours CEO Denise Dignam and CFO Shane Hostetter as control persons over statements that allegedly overstated Opteon aftermarket demand. It also alleges that the two executives sold more than $485,000 of company stock during the Class Period Important Information Regarding Section 20(a) Individual Liability Claims: The lawsuit names Chemours CEO Denise Dignam and CFO Shane Hostetter as control persons over statements that allegedly overstated Opteon aftermarket demand. It also alleges that the two executives sold more than $485,000 of company stock during the Class Period

news source

GlobeNewsWire • 4 hours ago

news preview

The Chemours Company (NYSE: CC) SHAREHOLDER ALERT: Investors With Losses May Seek to Lead the Class Action in The Chemours Company Securities Lawsuit - Contact Portnoy Law Firm

LOS ANGELES, Nov. 17, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm notifies investors in The Chemours Compmany (NYSE: CC) that a securities class action lawsuit has been filed on behalf of shareholders who purchased or otherwise acquired Chemours common stock between February 20, 2026 and August 4, 2026, inclusive (the 'Class Period'). Find out if you qualify to recover your per-share losses by choosing to join the class action and submit your trade details.

news source

GlobeNewsWire • 4 hours ago

news preview

SHAREHOLDER ALERT: Bronstein Gewirtz & Grossman, LLC Announces Class Action Against Chemours Company (NYSE: CC) — Investors Who Suffered Losses Are Encouraged to Contact the Firm

Lead Plaintiff Deadline: December 7, 2026. Investors who purchased (NYSE: CC) securities between February 20, 2026 and August 4, 2026 may be eligible to recover losses.

news source

GlobeNewsWire • 2 hours ago

news preview

Interested in Leading The Chemours Company Class Action Lawsuit? Contact Robbins LLP for Information About Your Rights

SAN DIEGO, Nov. 17, 2026 (GLOBE NEWSWIRE) -- Shareholder rights law firm Robbins LLP reminds investors that a class action was filed on behalf of persons or entities who purchased or otherwise acquired The Chemours Company (NYSE: CC) securities between February 20, 2026 and August 4, 2026, inclusive (the “Class Period”). Chemours offers a range of industrial and specialty chemical products for markets including, as relevant here, refrigeration and air conditioning.

news source

GlobeNewsWire • 4 hours ago

news preview

CC Loss Alert: Chemours Investors Sued for Securities Fraud in Connection with 18% Stock Drop and Alleged Misrepresentations about its Opteon Demand

Chemours has been sued for securities fraud after its stock plummeted 18.63% because Chemours allegedly misrepresented the strength of demand for its Opteon products. NEW YORK, Nov. 17, 2026 /PRNewswire/ -- Leading securities law firm Bleichmar Fonti & Auld LLP  announces that a class action lawsuit has been filed against The Chemours Company (NYSE:CC) and certain of the company's senior executives for securities fraud after a significant stock drop resulting from potential violations of the federal securities laws.

news source

PRNewsWire • 8 hours ago

news preview

DEADLINE ALERT for The Chemours Company (CC), Compass, Inc. (COMP), and Millrose Properties, Inc. (MRP): The Law Offices of Frank R. Cruz Reminds Investors of Lead Plaintiff Deadlines in Securities Fraud Class Actions

Investors in The Chemours Company, Compass, Inc., and Millrose Properties, Inc. have upcoming deadlines to seek lead plaintiff appointment in pending securities class actions Investors in The Chemours Company, Compass, Inc., and Millrose Properties, Inc. have upcoming deadlines to seek lead plaintiff appointment in pending securities class actions

news source

GlobeNewsWire • 2 hours ago

news preview

CC Deadline Alert: Levi & Korsinsky Reminds The Chemours Company (CC) Investors of Securities Class Action Deadline on December 7, 2026

Chemours shares shed $3.34 in a single session after a cut to 2026 earnings guidance. The lawsuit alleges that management overstated Opteon aftermarket demand while an oversupplied refrigerant channel weighed on sales. Chemours shares shed $3.34 in a single session after a cut to 2026 earnings guidance. The lawsuit alleges that management overstated Opteon aftermarket demand while an oversupplied refrigerant channel weighed on sales.

news source

GlobeNewsWire • Nov 16, 2026

news preview

Investor Notice: Chemours (NYSE:CC) Sued for Securities Fraud after Opteon Demand Issues Cause 18% Stock Drop – Contact BFA Law before Class Action Deadline

NEW YORK, Nov. 16, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against The Chemours Company (NYSE:CC) and certain of the company's senior executives for securities fraud after a significant stock drop resulting from potential violations of the federal securities laws. If you invested in Chemours, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/chemours-class-action-lawsuit.

news source

GlobeNewsWire • Nov 16, 2026

news preview

CC Investors Have Opportunity to Lead The Chemours Company Securities Fraud Lawsuit with SBS Law

LOS ANGELES, Nov. 16, 2026 /PRNewswire/ -- Schall, Brown & Schwartz LLP ("SBS"), a national shareholder rights litigation firm, reminds investors of a class action lawsuit against The Chemours Company ("Chemours" or "the Company") (NYSE: CC) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholders who purchased shares of CC during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointments.

news source

PRNewsWire • a day ago

news preview

CC UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds The Chemours (CC) Investors of Securities Class Action Lawsuit Deadline on December 7, 2026

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In The Chemours To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in The Chemours between February 20, 2026 and August 4, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] New York, New York--(Newsfile Corp. - November 16, 2026) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against The Chemours Company ("The Chemours" or the "Company") (NYSE: CC) and reminds investors of the December 7, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

news source

Newsfile Corp • 21 hours ago

news preview

¹ Disclosures

Get started with M1

Invest in Chemours Company (The)

Open an M1 investment account to buy and sell Chemours Company (The) commission-free¹. Build wealth for the long term using automated trading and transfers.

Invest in CC on M1